Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in joint preservation and regenerative solutions, announced that it filed the third and final module of its Premarket Approval application (PMA ...
Q3 2025 Earnings Call Transcript November 5, 2025 Anika Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback